Soleus Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
ACA
UOC
BCM
TAL
Soleus Capital Management's ISEE Position: Q2 2023 in Review
Soleus Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 2,127,043 shares — an estimated $51.8M sold.
Soleus Capital Management first reported a position in ISEE in Q4 2019 and held it in 14 quarters. The position peaked at $51.8M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.
- Soleus Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Soleus Capital Management sold 2,127,043 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $51.8M.
- Soleus Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 14 quarters.
- Soleus Capital Management's IVERIC bio, Inc. Common Stock position peaked at $51.8M in Q1 2023.
- 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.
Based on Soleus Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.